Prognostic factors for death after an isolated local recurrence in patients with early‐stage breast carcinoma

The authors analyzed the outcome of patients with early‐stage breast carcinoma after an isolated local recurrence, taking into account initial tumor characteristics and the type of initial treatment and local salvage treatment.

[1]  E van der Schueren,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2001, Journal of the National Cancer Institute.

[2]  A. van Langenberg.  Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node‐negative breast cancer , 2000, The British journal of surgery.

[3]  J. Peterse,et al.  Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. , 1999, European journal of cancer.

[4]  M Tubiana,et al.  The link between local recurrence and distant metastases in human breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[5]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[6]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[7]  M. Castiglione,et al.  Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer. , 1996, European journal of cancer.

[8]  R. Arriagada,et al.  Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Reiss,et al.  Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Arriagada,et al.  Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.

[12]  E. Zubizarreta,et al.  Breast conservation treatment of early stage breast cancer: patterns of failure. , 1995, International journal of radiation oncology, biology, physics.

[13]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[14]  A. Hart,et al.  Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. , 1995, European journal of cancer.

[15]  F. Cavalli,et al.  First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Whelan,et al.  Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. , 1994, International journal of radiation oncology, biology, physics.

[17]  S. Schnitt,et al.  Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Perez,et al.  Locoregional Recurrence of Breast Cancer: A Retrospective Comparison of Irradiation Alone Versus Irradiation and Systemic Therapy , 1992, American journal of clinical oncology.

[19]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[20]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[21]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[22]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[23]  C. Redmond,et al.  Significance of ipsilateral breast tumour recurrence after lumpectomy , 1991, The Lancet.

[24]  D. Schultz,et al.  The results of radiation therapy for isolated local regional recurrence after mastectomy. , 1991, International journal of radiation oncology, biology, physics.

[25]  D. Fischer,et al.  Prognosis following local recurrence in the conservatively treated breast cancer patient. , 1991, International journal of radiation oncology, biology, physics.

[26]  B. Koffmann,et al.  [Clinical course of recurrent and metastatic disease in breast cancer]. , 1991, Revista medica de Chile.

[27]  C. Bressac,et al.  Is breast conservation after local recurrence feasible? , 1991, European journal of cancer.

[28]  A. Luini,et al.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. , 1990, European journal of cancer.

[29]  C. Bressac,et al.  The prognostic significance of late local recurrence after breast-conserving therapy. , 1990, International journal of radiation oncology, biology, physics.

[30]  P. Vico,et al.  Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[32]  S. Schnitt,et al.  Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. , 1989, International journal of radiation oncology, biology, physics.

[33]  B. Cady,et al.  The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. , 1987, Cancer.

[34]  B. Fineberg,et al.  Prognostic indicators in patients with isolated local–regional recurrence of breast cancer , 1981, Cancer.

[35]  D.,et al.  Regression Models and Life-Tables , 2022 .